Literature DB >> 9345097

Rufous oculocutaneous albinism in southern African Blacks is caused by mutations in the TYRP1 gene.

P Manga1, J G Kromberg, N F Box, R A Sturm, T Jenkins, M Ramsay.   

Abstract

Oculocutaneous albinism (OCA) is the most common autosomal recessive disorder among southern African Blacks. There are three forms that account for almost all OCA types in this region. Tyrosinase-positive OCA (OCA2), which is the most common, affects approximately 1/3,900 newborns and has a carrier frequency of approximately 1/33. It is caused by mutations in the P gene on chromosome 15. Brown OCA (BOCA) and rufous OCA (ROCA) account for the majority of the remaining phenotypes. The prevalence of BOCA is unknown, but for ROCA it is approximately 1/8,500. Linkage analysis performed on nine ROCA families showed that ROCA was linked to an intragenic marker at the TYRP1 locus (maximum LOD score = 3.80 at straight theta=.00). Mutation analysis of 19 unrelated ROCA individuals revealed a nonsense mutation at codon 166 (S166X) in 17 (45%) of 38 ROCA chromosomes, and a second mutation (368delA) was found in an additional 19 (50%) of 38 chromosomes; mutations were not identified in the remaining 2 ROCA chromosomes. In one family, two siblings with a phenotypically unclassified form of albinism were found to be compound heterozygotes for mutations (S166X/368delA) at the TYRP1 locus and were heterozygous for a common 2.7-kb deletion in the P gene. These findings have highlighted the influence of genetic background on phenotype, in which the genotype at one locus can be influenced by the genotype at a second locus, leading to a modified phenotype. ROCA, which in southern African Blacks is caused by mutations in the TYRP1 gene, therefore should be referred to as "OCA3," since this is the third locus that has been shown to cause an OCA phenotype in humans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9345097      PMCID: PMC1716031          DOI: 10.1086/301603

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

1.  Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".

Authors:  R E Boissy; H Zhao; W S Oetting; L M Austin; S C Wildenberg; Y L Boissy; Y Zhao; R A Sturm; V J Hearing; R A King; J J Nordlund
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

2.  The tyrosinase-positive oculocutaneous albinism gene shows locus homogeneity on chromosome 15q11-q13 and evidence of multiple mutations in southern African negroids.

Authors:  M A Kedda; G Stevens; P Manga; C Viljoen; T Jenkins; M Ramsay
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

3.  Chromosomal structure of the human TYRP1 and TYRP2 loci and comparison of the tyrosinase-related protein gene family.

Authors:  R A Sturm; B J O'Sullivan; N F Box; A G Smith; S E Smit; E R Puttick; P G Parsons; I S Dunn
Journal:  Genomics       Date:  1995-09-01       Impact factor: 5.736

4.  Molecular characterization of a human tyrosinase-related-protein-2 cDNA. Patterns of expression in melanocytic cells.

Authors:  B Bouchard; V Del Marmol; I J Jackson; D Cherif; L Dubertret
Journal:  Eur J Biochem       Date:  1994-01-15

5.  Assignment of the tyrosinase-related protein-2 gene (TYRP2) to human chromosome 13q31-q32 by fluorescence in situ hybridization: extended synteny with mouse chromosome 14.

Authors:  R A Sturm; E Baker; G R Sutherland
Journal:  Genomics       Date:  1994-05-01       Impact factor: 5.736

6.  A new enzymatic function in the melanogenic pathway. The 5,6-dihydroxyindole-2-carboxylic acid oxidase activity of tyrosinase-related protein-1 (TRP1).

Authors:  C Jiménez-Cervantes; F Solano; T Kobayashi; K Urabe; V J Hearing; J A Lozano; J C García-Borrón
Journal:  J Biol Chem       Date:  1994-07-08       Impact factor: 5.157

7.  African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism.

Authors:  D Durham-Pierre; J M Gardner; Y Nakatsu; R A King; U Francke; A Ching; R Aquaron; V del Marmol; M H Brilliant
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

8.  An intragenic deletion of the P gene is the common mutation causing tyrosinase-positive oculocutaneous albinism in southern African Negroids.

Authors:  G Stevens; J van Beukering; T Jenkins; M Ramsay
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

9.  Detection of a Tsp509I polymorphism in the 3' UTR of the human tyrosinase related protein-1 (TYRP) gene.

Authors:  S C Wildenberg; R A King; W S Oetting
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

10.  The mouse brown (b) locus protein has dopachrome tautomerase activity and is located in lysosomes in transfected fibroblasts.

Authors:  A J Winder; A Wittbjer; E Rosengren; H Rorsman
Journal:  J Cell Sci       Date:  1993-09       Impact factor: 5.285

View more
  28 in total

1.  Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4.

Authors:  J M Newton; O Cohen-Barak; N Hagiwara; J M Gardner; M T Davisson; R A King; M H Brilliant
Journal:  Am J Hum Genet       Date:  2001-09-26       Impact factor: 11.025

2.  Relationship between foveal cone specialization and pit morphology in albinism.

Authors:  Melissa A Wilk; John T McAllister; Robert F Cooper; Adam M Dubis; Teresa N Patitucci; Phyllis Summerfelt; Jennifer L Anderson; Kimberly E Stepien; Deborah M Costakos; Thomas B Connor; William J Wirostko; Pei-Wen Chiang; Alfredo Dubra; Christine A Curcio; Murray H Brilliant; C Gail Summers; Joseph Carroll
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-20       Impact factor: 4.799

3.  Molecular and clinical characterization of albinism in a large cohort of Italian patients.

Authors:  Annagiusi Gargiulo; Francesco Testa; Settimio Rossi; Valentina Di Iorio; Simona Fecarotta; Teresa de Berardinis; Antonello Iovine; Adriano Magli; Sabrina Signorini; Elisa Fazzi; Maria Silvana Galantuomo; Maurizio Fossarello; Sandro Montefusco; Alfredo Ciccodicola; Alberto Neri; Claudio Macaluso; Francesca Simonelli; Enrico Maria Surace
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-14       Impact factor: 4.799

4.  Informed reasoning: repositioning of nitisinone to treat oculocutaneous albinism.

Authors:  Prashiela Manga; Seth J Orlow
Journal:  J Clin Invest       Date:  2011-10       Impact factor: 14.808

5.  Genome-wide transcriptome analysis of human epidermal melanocytes.

Authors:  Kirk D Haltaufderhyde; Elena Oancea
Journal:  Genomics       Date:  2014-10-30       Impact factor: 5.736

6.  Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.

Authors:  Monika B Dolinska; Nicole J Kus; S Katie Farney; Paul T Wingfield; Brian P Brooks; Yuri V Sergeev
Journal:  Pigment Cell Melanoma Res       Date:  2017-01       Impact factor: 4.693

7.  A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: Implications for vitiligo.

Authors:  Prashiela Manga; David Sheyn; Fan Yang; Rangaprasad Sarangarajan; Raymond E Boissy
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

8.  MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2).

Authors:  Richard A King; Rebecca K Willaert; Ramona M Schmidt; Jacy Pietsch; Sarah Savage; Marcia J Brott; James P Fryer; C Gail Summers; William S Oetting
Journal:  Am J Hum Genet       Date:  2003-07-22       Impact factor: 11.025

9.  Report of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigree.

Authors:  Jason E Hawkes; Pamela B Cassidy; Prashiela Manga; Raymond E Boissy; David Goldgar; Lisa Cannon-Albright; Scott R Florell; Sancy A Leachman
Journal:  J Dermatol Sci       Date:  2012-10-13       Impact factor: 4.563

10.  Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan.

Authors:  Katsuhiko Inagaki; Tamio Suzuki; Hiroshi Shimizu; Norihisa Ishii; Yoshinori Umezawa; Joji Tada; Noriaki Kikuchi; Minoru Takata; Kenji Takamori; Mari Kishibe; Michi Tanaka; Yoshinori Miyamura; Shiro Ito; Yasushi Tomita
Journal:  Am J Hum Genet       Date:  2004-02-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.